GlobeNewswire 7/8/2024 Goliath Starts Drilling With Two Rigs Testing Surebet Feeder Source And Magnitude, Plus Three New Ou...
GlobeNewswire 7/2/2024 Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in ...
GlobeNewswire 7/1/2024 Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire 6/26/2024 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 6/19/2024 AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire 6/19/2024 EXTENSIVE Zn-Pb-Ag-MINERALIZATION IN GALLERIES G2 AND G7, BIHOR SUD PROJECT, ROMANIA
GlobeNewswire 6/11/2024 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/5/2024 Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire 6/3/2024 Goliath Mobilizes For 15,000 Meter Drill Program To Test Surebet Feeder Source Plus Three New High-G...
GlobeNewswire 6/3/2024 AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
GlobeNewswire 6/3/2024 AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire 6/1/2024 Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...
GlobeNewswire 5/31/2024 TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire 5/30/2024 Genius Metals Completes a High-Resolution MAG Survey on its Dissimieux Phosphate-Titanium-Rare Earth...
GlobeNewswire 5/30/2024 Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire 5/28/2024 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire 5/28/2024 TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire 5/25/2024 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire 5/21/2024 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 5/9/2024 Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 5/1/2024 COMSTOCK RESOURCES, INC. REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
GlobeNewswire 4/22/2024 GDC Enhances TikTok Marketing for Small and Medium-sized Businesses with Comprehensive Service Suite
GlobeNewswire 4/18/2024 TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire 4/17/2024 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
Newsfile Corp 4/16/2024 Appia Files NI 43-101 Technical Report on Maiden Indicated and Inferred Mineral Resource Estimate fo...